🔗 Share this article

An underground market for unlicensed slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Experimental Treatment Acquiring Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Followers are encouraged to message these profiles privately for supplier links, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust trade exists on Telegram, where communities with thousands of members share “before and after” photos, injection guides and claims of next-day British shipping. Vendors market the drug there before redirecting buyers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an experimental injectable created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Experts Express Concerns

However, doctors and chemists have cautions that the distribution of what remains an unapproved medication in the United Kingdom is a cause for concern and could lead to individuals administering products of unknown origin.

Some professionals said the demand for retatrutide could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for human use under the British medical regulations.

Several content creators try to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still breach medicines, marketing, and customer laws, potentially leading to penalties, legal action or imprisonment.

Service Response and Content Elimination

Based on TikTok, the platform has removed problematic material and banned associated hashtags and search suggestions. The organization stated it was committed to keeping the platform safe and allocating resources in strengthening enforcement strategies.

Online Trading Activities

Research also discovered groups with up to nine thousand members selling the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly brings up channels with numerous of users, populated with photos of weight loss, glowing reviews and step-by-step instructions for mixing or injecting at residence.

Within minutes of joining one community, a seller shared contact information, where the majority of transactions occur. The vendor provided an instruction manual and promised delivery within two days. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about body mass, health issues or past usage.

Product Details and Pricing

Inside these communities, messages show black plastic packages with Royal Mail labels, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with purified liquid, or ready-to-use pens typically sold at £160 for 20mg. When asked how long a injector should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for the messaging service stated it regularly monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering substances they can’t verify. Although the science behind retatrutide is sound, these digital versions may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, patients are turning to social media. But fake treatments are highly risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her team has already encountered individuals harmed by self-injection from unverified sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”

Producer Statement

A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a Lilly experimental product not yet authorized … may expose patients to possibly significant health risks”.